List of Tables
Table 1. Global Monoclonal Antibody ADC Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Monoclonal Antibody ADC Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Monoclonal Antibody ADC Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Monoclonal Antibody ADC Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Monoclonal Antibody ADC Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Monoclonal Antibody ADC Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Monoclonal Antibody ADC Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Monoclonal Antibody ADC Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Monoclonal Antibody ADC Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Monoclonal Antibody ADC Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Monoclonal Antibody ADC Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Monoclonal Antibody ADC Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Monoclonal Antibody ADC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody ADC Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Monoclonal Antibody ADC Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Monoclonal Antibody ADC Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Monoclonal Antibody ADC Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Monoclonal Antibody ADC Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Monoclonal Antibody ADC Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Monoclonal Antibody ADC Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Monoclonal Antibody ADC Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Monoclonal Antibody ADC Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Monoclonal Antibody ADC Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Monoclonal Antibody ADC Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Monoclonal Antibody ADC Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Monoclonal Antibody ADC Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Monoclonal Antibody ADC Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Monoclonal Antibody ADC Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Monoclonal Antibody ADC Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Monoclonal Antibody ADC Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Monoclonal Antibody ADC Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Monoclonal Antibody ADC Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Monoclonal Antibody ADC Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Monoclonal Antibody ADC Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Monoclonal Antibody ADC Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Monoclonal Antibody ADC Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Monoclonal Antibody ADC Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Monoclonal Antibody ADC Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Monoclonal Antibody ADC Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Monoclonal Antibody ADC Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Monoclonal Antibody ADC Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Monoclonal Antibody ADC Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Monoclonal Antibody ADC Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Monoclonal Antibody ADC Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Monoclonal Antibody ADC Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Monoclonal Antibody ADC Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Monoclonal Antibody ADC Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Monoclonal Antibody ADC Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Monoclonal Antibody ADC Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Monoclonal Antibody ADC Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Monoclonal Antibody ADC Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Monoclonal Antibody ADC Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Monoclonal Antibody ADC Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Monoclonal Antibody ADC Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Monoclonal Antibody ADC Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Monoclonal Antibody ADC Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Monoclonal Antibody ADC Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Monoclonal Antibody ADC Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Seattle Company Information
Table 71. Seattle Description and Business Overview
Table 72. Seattle Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Seattle Monoclonal Antibody ADC Drugs Product
Table 74. Seattle Recent Developments/Updates
Table 75. Roche Company Information
Table 76. Roche Description and Business Overview
Table 77. Roche Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Roche Monoclonal Antibody ADC Drugs Product
Table 79. Roche Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Pfizer Monoclonal Antibody ADC Drugs Product
Table 84. Pfizer Recent Developments/Updates
Table 85. AstraZeneca Company Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AstraZeneca Monoclonal Antibody ADC Drugs Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Immunomedics Company Information
Table 91. Immunomedics Description and Business Overview
Table 92. Immunomedics Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Immunomedics Monoclonal Antibody ADC Drugs Product
Table 94. Immunomedics Recent Developments/Updates
Table 95. GSK Company Information
Table 96. GSK Description and Business Overview
Table 97. GSK Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. GSK Monoclonal Antibody ADC Drugs Product
Table 99. GSK Recent Developments/Updates
Table 100. ADC Therapeutics Company Information
Table 101. ADC Therapeutics Description and Business Overview
Table 102. ADC Therapeutics Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. ADC Therapeutics Monoclonal Antibody ADC Drugs Product
Table 104. ADC Therapeutics Recent Developments/Updates
Table 105. Lepu Biopharma Company Information
Table 106. Lepu Biopharma Description and Business Overview
Table 107. Lepu Biopharma Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Lepu Biopharma Monoclonal Antibody ADC Drugs Product
Table 109. Lepu Biopharma Recent Developments/Updates
Table 110. Shanghai Junshi Biosciences Company Information
Table 111. Shanghai Junshi Biosciences Description and Business Overview
Table 112. Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Product
Table 114. Shanghai Junshi Biosciences Recent Developments/Updates
Table 115. RemeGen Company Information
Table 116. RemeGen Description and Business Overview
Table 117. RemeGen Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. RemeGen Monoclonal Antibody ADC Drugs Product
Table 119. RemeGen Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Monoclonal Antibody ADC Drugs Distributors List
Table 123. Monoclonal Antibody ADC Drugs Customers List
Table 124. Monoclonal Antibody ADC Drugs Market Trends
Table 125. Monoclonal Antibody ADC Drugs Market Drivers
Table 126. Monoclonal Antibody ADC Drugs Market Challenges
Table 127. Monoclonal Antibody ADC Drugs Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Monoclonal Antibody ADC Drugs
Figure 2. Global Monoclonal Antibody ADC Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Monoclonal Antibody ADC Drugs Market Share by Type: 2024 & 2031
Figure 4. CD30 Target Antigen Product Picture
Figure 5. HER2 Target Antigen Product Picture
Figure 6. CD22 Target Antigen Product Picture
Figure 7. CD33 Target Antigen Product Picture
Figure 8. Nectin-4 Target Antigen Product Picture
Figure 9. Others Product Picture
Figure 10. Global Monoclonal Antibody ADC Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Monoclonal Antibody ADC Drugs Market Share by Application: 2024 & 2031
Figure 12. Lymphoma
Figure 13. Breast Cancer
Figure 14. Leukemia
Figure 15. Myeloma
Figure 16. Others
Figure 17. Global Monoclonal Antibody ADC Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Monoclonal Antibody ADC Drugs Market Size (2020-2031) & (US$ Million)
Figure 19. Global Monoclonal Antibody ADC Drugs Sales (2020-2031) & (K Units)
Figure 20. Global Monoclonal Antibody ADC Drugs Average Price (US$/Unit) & (2020-2031)
Figure 21. Monoclonal Antibody ADC Drugs Report Years Considered
Figure 22. Monoclonal Antibody ADC Drugs Sales Share by Manufacturers in 2024
Figure 23. Global Monoclonal Antibody ADC Drugs Revenue Share by Manufacturers in 2024
Figure 24. Global 5 and 10 Largest Monoclonal Antibody ADC Drugs Players: Market Share by Revenue in Monoclonal Antibody ADC Drugs in 2024
Figure 25. Monoclonal Antibody ADC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Global Monoclonal Antibody ADC Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 27. North America Monoclonal Antibody ADC Drugs Sales Market Share by Country (2020-2031)
Figure 28. North America Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2020-2031)
Figure 29. United States Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Canada Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Country (2020-2031)
Figure 32. Europe Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2020-2031)
Figure 33. Germany Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. France Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. U.K. Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Italy Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Russia Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Asia Pacific Monoclonal Antibody ADC Drugs Sales Market Share by Region (2020-2031)
Figure 39. Asia Pacific Monoclonal Antibody ADC Drugs Revenue Market Share by Region (2020-2031)
Figure 40. China Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Japan Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. South Korea Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. India Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Australia Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. China Taiwan Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Monoclonal Antibody ADC Drugs Sales Market Share by Country (2020-2031)
Figure 48. Latin America Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Monoclonal Antibody ADC Drugs Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Monoclonal Antibody ADC Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Monoclonal Antibody ADC Drugs by Type (2020-2031)
Figure 58. Global Revenue Market Share of Monoclonal Antibody ADC Drugs by Type (2020-2031)
Figure 59. Global Monoclonal Antibody ADC Drugs Price (US$/Unit) by Type (2020-2031)
Figure 60. Global Sales Market Share of Monoclonal Antibody ADC Drugs by Application (2020-2031)
Figure 61. Global Revenue Market Share of Monoclonal Antibody ADC Drugs by Application (2020-2031)
Figure 62. Global Monoclonal Antibody ADC Drugs Price (US$/Unit) by Application (2020-2031)
Figure 63. Monoclonal Antibody ADC Drugs Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
